Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Sep;26(3):351–353. doi: 10.1128/aac.26.3.351

Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli.

W L Wang, L B Reller, M J Blaser
PMCID: PMC176168  PMID: 6508265

Abstract

To determine whether employing antibiograms is useful to separate Campylobacter jejuni and Campylobacter coli, we determined the MICs of 12 antibiotics for 104 human clinical strains and 74 swine strains. Of 74 swine strains, 5 (7%) were hippurate positive, as were 93 (89%) of 104 human strains. The 12 antimicrobial agents tested were ampicillin, amoxicillin, clindamycin, chloramphenicol, erythromycin, furazolidone, norfloxacin, nalidixic acid, rosoxacin, rosaramicin, tetracycline, and Sch 32063. Isolates from humans were significantly (P less than 0.001) more susceptible than swine strains to clindamycin, erythromycin, rosaramicin, and Sch 32063. Of 11 human hippurate-negative strains, 3 (27%) were resistant to clindamycin, erythromycin, rosaramicin, and Sch 32063, compared with 1 of 93 (1%) hippurate-positive strains. Nearly all human and swine strains were susceptible to furazolidone and nalidixic acid. Campylobacter isolates from humans and swine have different antibiograms, and the susceptibility to certain antibiotics, such as clindamycin, may be helpful for differentiation of C. jejuni from C. coli.

Full text

PDF
352

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blaser M. J., Parsons R. B., Wang W. L. Acute colitis caused by Campylobacter fetus ss. jejuni. Gastroenterology. 1980 Mar;78(3):448–453. [PubMed] [Google Scholar]
  2. Blaser M. J., Reller L. B. Campylobacter enteritis. N Engl J Med. 1981 Dec 10;305(24):1444–1452. doi: 10.1056/NEJM198112103052404. [DOI] [PubMed] [Google Scholar]
  3. Brunton W. A., Wilson A. M., Macrae R. M. Erythromycin-resistant campylobacters. Lancet. 1978 Dec 23;2(8104-5):1385–1385. doi: 10.1016/s0140-6736(78)92027-5. [DOI] [PubMed] [Google Scholar]
  4. Butzler J. P., Skirrow M. B. Campylobacter enteritis. Clin Gastroenterol. 1979 Sep;8(3):737–765. [PubMed] [Google Scholar]
  5. Harvey S. M. Hippurate hydrolysis by Campylobacter fetus. J Clin Microbiol. 1980 Apr;11(4):435–437. doi: 10.1128/jcm.11.4.435-437.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Karmali M. A., De Grandis S., Fleming P. C. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation. Antimicrob Agents Chemother. 1980 Dec;18(6):948–951. doi: 10.1128/aac.18.6.948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kowalec J. K., Kaminski Z. C., Krey P. R. Campylobacter arthritis. Arthritis Rheum. 1980 Jan;23(1):92–94. doi: 10.1002/art.1780230115. [DOI] [PubMed] [Google Scholar]
  8. Luechtefeld N. W., Wang W. L. Hippurate hydrolysis by and triphenyltetrazolium tolerance of Campylobacter fetus. J Clin Microbiol. 1982 Jan;15(1):137–140. doi: 10.1128/jcm.15.1.137-140.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Shanker S., Sorrell T. C. Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology. 1983 Jan;15(1):61–63. doi: 10.3109/00313028309061403. [DOI] [PubMed] [Google Scholar]
  10. Skirrow M. B., Benjamin J. '1001' Campylobacters: cultural characteristics of intestinal campylobacters from man and animals. J Hyg (Lond) 1980 Dec;85(3):427–442. doi: 10.1017/s0022172400063506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Smibert R. M. The genus Campylobacter. Annu Rev Microbiol. 1978;32:673–709. doi: 10.1146/annurev.mi.32.100178.003325. [DOI] [PubMed] [Google Scholar]
  12. Vanhoof R., Gordts B., Dierickx R., Coignau H., Butzler J. P. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother. 1980 Jul;18(1):118–121. doi: 10.1128/aac.18.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Vanhoof R., Vanderlinden M. P., Dierickx R., Lauwers S., Yourassowsky E., Butzler J. P. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents. Antimicrob Agents Chemother. 1978 Oct;14(4):553–556. doi: 10.1128/aac.14.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Walder M. Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents. Antimicrob Agents Chemother. 1979 Jul;16(1):37–39. doi: 10.1128/aac.16.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES